All Covid-19 updates and resources can be found here: COVID-19 INFORMATION FOR CF COMMUNITY
Skip To Content
Volunteer Advocate


CARSTAR to Provide Travel and Accommodations for Cystic Fibrosis Study Participants
June 19, 2018

Cystic Fibrosis Canada’s National Partner Provides Financial Assistance for CFIT Participants


TORONTO (June 19, 2018) – Cystic Fibrosis Canada national partner, CARSTAR, will fund travel and accommodations for participants of the Cystic Fibrosis Individualized Therapy (CFIT) study. With CARSTAR’s generous support, participants with cystic fibrosis (CF) from across Canada will travel to The Hospital for Sick Children in Toronto (SickKids) to take part in the ground-breaking study.

The Program for Individualized Cystic Fibrosis Therapy is a national resource dedicated to individualized CF drug discovery. With more than two thousand different CF gene mutations, each patient is different. The goal of the program is to ensure every CF patient has access to the life-changing treatments that will work best for them. To promote the study, CARSTAR produced a video to share with the Canadian CF community.

“We are delighted that CARSTAR is supporting CFIT, and is providing Canadians with cystic fibrosis from coast to coast the opportunity to participate in a world-class study,” said Dr. John Wallenburg, Chief Scientific Officer at Cystic Fibrosis Canada. “CFIT will benefit the international cystic fibrosis community for years to come, and will help take the guess-work out of which therapies will benefit which mutations of this devastating disease.”

“Our relationship with Cystic Fibrosis Canada started when a franchise partners granddaughter was diagnosed with CF, so we hosted a small golf tournament to fundraise for the organization,” says Michael Macaluso, CARSTAR President. “Over 20 years later, fighting cystic fibrosis has become our North American cause, with our franchise partners building longstanding relationships with their local chapters, and this charity being engrained in our networks culture.”

The #RoadToResearch partnership is an exciting chapter in the Cystic Fibrosis Canada and CARSTAR’S 21-year partnership. With over 270 locations across Canada, CARSTAR is the national leader of auto collision and auto glass services. Since 1997, Cystic Fibrosis Canada has been CARSTAR’S charity of choice. Through various fundraising events including golf tournaments, sports marketing promotions and the annual Soaps it Up National Car Wash, CARSTAR and its franchise partners reached the $3 million milestone in donations to Cystic Fibrosis Canada in 2016. 




Cystic Fibrosis

Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults. It is a multi-system disease that affects mainly the lungs and the digestive system. In the lungs, where the effects are most devastating, a build-up of thick mucus causes severe respiratory problems. Mucus also builds up in the digestive tract, making it difficult to digest and absorb nutrients from food. As improved therapies have helped to address the malnutrition issues, ultimately most deaths related to cystic fibrosis are due to lung disease. There is no cure.

Cystic Fibrosis Canada

Cystic Fibrosis Canada is one of the world’s top three charitable organizations committed to finding a cure for cystic fibrosis and is an internationally-recognized leader in funding CF research, innovation, and clinical care. We invest more funding in life-saving CF research and care than any other non-governmental agency in Canada. Since 1960, Cystic Fibrosis Canada has invested more than $253 million in leading research, care and advocacy, resulting in one of the world’s highest survival rates for Canadians living with cystic fibrosis. For more information, visit


For more information, contact:
Nicole Young, Director, Corporate Communications
Cystic Fibrosis Canada
Tel: 416-485-9149 ext. 235
Tel: 1-800-378-2233 ext. 235

Jennifer Stranges, Associate, Corporate Communications
Cystic Fibrosis Canada
Tel: 416-485-9149 ext. 290
Tel: 1-800-378-2233 ext. 290

Back to Listing